“Targeting the Beta-Catenin Pathway to Overcome Immunotherapy Resistance of Beta-catenin Expressing Tumors” and “Diving into the Deep End: Minimal Residual Disease in Multiple Myeloma” |
10/15/2018 - 12:00pm to 1:00pm |
“Center for Clinical Cancer Genetics: 2018 Program Update” |
10/08/2018 - 12:00pm to 1:00pm |
“Investigating Quality of Life and Mental Health Outcomes in Older Adults with Sickle cell Disease” and “Genomic Drivers of Immunogenicity and Immune Escape Mechanisms in DLBCL” |
10/01/2018 - 12:00pm to 1:00pm |
“Incorporating the Transcriptome to Improve Population-Specific Understanding and Prognosis in Breast Cancer Patients” |
09/24/2018 - 12:00pm to 1:00pm |
“Novel Approaches in Gastrointestinal Malignancies” |
09/10/2018 - 12:00pm to 1:00pm |
“Refining Therapies in Aerodigestive Malignancies” |
08/27/2018 - 12:00pm to 1:00pm |
“Translating the Genome in Gastroesophageal Cancer” |
08/20/2018 - 12:00pm to 1:00pm |
“TCR-T Cells: The Answer to Solid Tumor Immunology” and “Prognostic Implications of Driver Mutations in AML” |
08/13/2018 - 12:00pm to 1:00pm |
“Interstitial-Targeted Treatment of Cerebral Metastasis” |
08/06/2018 - 12:00pm to 1:00pm |
“Incidental Germline Findings in Next-Generation Sequencing: Incidence and Management Approaches” and “Management of Chronic Myeloid Leukemia in Pregnancy” |
07/30/2018 - 12:00pm to 1:00pm |